UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Validated machine learning tools to distinguish immune checkpoint inhibitor, radiotherapy, COVID-19 and other infective pneumonitis

Radiotherapy and oncology, 2024-06, Vol.195, p.110266-110266, Article 110266

2024

Volltextzugriff (PDF)

27 Characteristics of lung cancer diagnosed through a Rapid Diagnostic Clinic

Lung cancer (Amsterdam, Netherlands), 2024-04, Vol.190, p.107588, Article 107588

2024

Volltextzugriff (PDF)

95 Lorlatinib in advanced ALK-rearranged NSCLC – real-world experience in a UK population

Lung cancer (Amsterdam, Netherlands), 2024-04, Vol.190, p.107656, Article 107656

2024

Volltextzugriff (PDF)

84 National Real World Study of Adjuvant Osimertinib in Resected EGFR Mutated Lung Cancer

Lung cancer (Amsterdam, Netherlands), 2024-04, Vol.190, p.107645, Article 107645

2024

Volltextzugriff (PDF)

66 - Clinical predictors of long-term efficacy of first-line pembrolizumab monotherapy in non-small cell lung cancer (NSCLC): an interim analysis of real-world data

Lung cancer (Amsterdam, Netherlands), 2022-03, Vol.165, p.S32-S32

2022

Volltextzugriff (PDF)

Clinical predictors of long-term efficacy of first-line pembrolizumab monotherapy in non-small cell lung cancer (NSCLC): an interim analysis of real-world data

Lung cancer (Amsterdam, Netherlands), 2022-03, Vol.165, p.S32

2022

Volltextzugriff (PDF)

Association of primary and community care services with emergency visits and hospital admissions at the end of life in people with cancer: a retrospective cohort study

BMJ open, 2022-02, Vol.12 (2), p.e054281-e054281

2022

Volltextzugriff (PDF)

Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19

JAMA network open, 2022-02, Vol.5 (2), p.e220130

2022

Volltextzugriff (PDF)

Lung cancer treatment during a pandemic: how have multi-disciplinary teams changed?

Lung cancer (Amsterdam, Netherlands), 2021-06, Vol.156, p.S18

2021

Volltextzugriff (PDF)

Increased emergency presentation of new lung cancer diagnoses and less treatment: a COVID legacy

Lung cancer (Amsterdam, Netherlands), 2021-06, Vol.156, p.S20

2021

Volltextzugriff (PDF)

Real-world outcomes using pembrolizumab plus pemetrexed-platinum in 1st line metastatic NSCLC compared to results reported from KEYNOTE-189: a multicentre experience

Lung cancer (Amsterdam, Netherlands), 2021-06, Vol.156, p.S46

2021

Volltextzugriff (PDF)

Pleomorphic lung carcinoma – a rare response to a rare tumour

Lung cancer (Amsterdam, Netherlands), 2021-06, Vol.156, p.S76

2021

Volltextzugriff (PDF)

Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score

Journal for immunotherapy of cancer, 2021-03, Vol.9 (3), p.e002277

2021

Volltextzugriff (PDF)

Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer

Journal for immunotherapy of cancer, 2021-03, Vol.9 (3), p.e001865

2021

Volltextzugriff (PDF)

COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study

The lancet oncology, 2020-10, Vol.21 (10), p.1309-1316

2020

Volltextzugriff (PDF)

Immunotherapy-induced endocrinopathies: assessment, management and monitoring

Therapeutic Advances in Endocrinology and Metabolism, 2019, Vol.10, p.2042018819896182

2019

Volltextzugriff (PDF)

A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer

Journal of thoracic oncology, 2016-07, Vol.11 (7), p.1029-1039

2016

Volltextzugriff (PDF)

An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients

Ecancermedicalscience, 2016-01, Vol.10, p.608-608

2016

Volltextzugriff (PDF)

TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells

Oncogene, 2015-04, Vol.34 (16), p.2138-2144

2015

Volltextzugriff (PDF)

B ritish HIV Association guidelines for HIV ‐associated malignancies 2014

HIV medicine, 2014-03, Vol.15 (S2), p.1-92

2014

Volltextzugriff (PDF)

British HIV Association guidelines for HIV‐associated malignancies 2014

HIV medicine, 2014-03, Vol.15, p.1-92

2014

Volltextzugriff (PDF)

Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK

AIDS (London), 2013-06, Vol.27 (10), p.1603-1613

2013

Volltextzugriff (PDF)

Nonmelanoma skin cancers among HIV-infected persons in the HAART era

Journal of acquired immune deficiency syndromes (1999), 2012-06, Vol.60 (2), p.e63

2012

Volltextzugriff (PDF)

Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman disease

Blood, 2011-07, Vol.118 (2), p.271-275

2011

Volltextzugriff (PDF)

Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease

Journal of clinical oncology, 2011-06, Vol.29 (18), p.2481-2486

2011

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Humans
(21)
Female
(15)
Male
(15)
Adult
(12)
Middle Aged
(12)
Aged
(11)
Oncology
(11)
Infectious Diseases
(9)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Cancer
(7)
Human Viral Diseases
(7)
Immunology
(7)
Prospective Studies
(7)
Viral Diseases
(7)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(7)
Antiretroviral Therapy, Highly Active
(6)
Hiv Infections - Complications
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Lung Cancer
(9)
Aids
(2)
Annals Of Internal Medicine
(2)
Blood
(2)
Hiv Medicine
(2)
Journal For Immunotherapy Of Cancer
(2)
Journal Of Acquired Immune Deficiency Syndromes
(2)
Bmj Open
(1)
Ecancermedicalscience
(1)
International Immunology
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Validated machine learning tools to distinguish immune checkpoint inhibitor, radiotherapy, COVID-19 and other infective pneumonitis

27 Characteristics of lung cancer diagnosed through a Rapid Diagnostic Clinic

95 Lorlatinib in advanced ALK-rearranged NSCLC – real-world experience in a UK population

84 National Real World Study of Adjuvant Osimertinib in Resected EGFR Mutated Lung Cancer

66 - Clinical predictors of long-term efficacy of first-line pembrolizumab monotherapy in non-small cell lung cancer (NSCLC): an interim analysis of real-world data

Clinical predictors of long-term efficacy of first-line pembrolizumab monotherapy in non-small cell lung cancer (NSCLC): an interim analysis of real-world data

Association of primary and community care services with emergency visits and hospital admissions at the end of life in people with cancer: a retrospective cohort study

Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19

Lung cancer treatment during a pandemic: how have multi-disciplinary teams changed?

Increased emergency presentation of new lung cancer diagnoses and less treatment: a COVID legacy

Real-world outcomes using pembrolizumab plus pemetrexed-platinum in 1st line metastatic NSCLC compared to results reported from KEYNOTE-189: a multicentre experience

Pleomorphic lung carcinoma – a rare response to a rare tumour

Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score

Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer

COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study

Immunotherapy-induced endocrinopathies: assessment, management and monitoring

A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer

An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients

TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells

B ritish HIV Association guidelines for HIV ‐associated malignancies 2014

British HIV Association guidelines for HIV‐associated malignancies 2014

Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK

Nonmelanoma skin cancers among HIV-infected persons in the HAART era

Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman disease

Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease

Suchergebnisse filtern